Captrust Financial Advisors Boosts Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Captrust Financial Advisors increased its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.4% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 26,499 shares of the medical equipment provider’s stock after buying an additional 376 shares during the quarter. Captrust Financial Advisors’ holdings in Intuitive Surgical were worth $13,831,000 as of its most recent SEC filing.

Other hedge funds have also recently made changes to their positions in the company. Cary Street Partners Financial LLC purchased a new position in shares of Intuitive Surgical in the fourth quarter worth about $220,000. Caxton Associates LP purchased a new stake in shares of Intuitive Surgical in the 4th quarter valued at $52,196,000. Brown Advisory Inc. boosted its holdings in shares of Intuitive Surgical by 5.8% in the 4th quarter. Brown Advisory Inc. now owns 1,746,131 shares of the medical equipment provider’s stock valued at $911,411,000 after acquiring an additional 95,249 shares during the last quarter. BW Gestao de Investimentos Ltda. acquired a new stake in shares of Intuitive Surgical in the fourth quarter worth $3,955,000. Finally, Baird Financial Group Inc. raised its holdings in shares of Intuitive Surgical by 23.4% during the fourth quarter. Baird Financial Group Inc. now owns 45,118 shares of the medical equipment provider’s stock worth $23,550,000 after purchasing an additional 8,551 shares during the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.

Intuitive Surgical Stock Performance

Shares of ISRG opened at $530.46 on Wednesday. The stock has a 50 day moving average price of $502.67 and a 200 day moving average price of $534.43. The stock has a market capitalization of $190.13 billion, a price-to-earnings ratio of 82.76, a PEG ratio of 5.85 and a beta of 1.70. Intuitive Surgical, Inc. has a one year low of $379.67 and a one year high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, beating analysts’ consensus estimates of $1.71 by $0.10. The business had revenue of $2.25 billion during the quarter, compared to analysts’ expectations of $2.19 billion. Intuitive Surgical had a net margin of 27.81% and a return on equity of 14.55%. During the same period in the prior year, the business earned $1.50 earnings per share. On average, analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Analyst Ratings Changes

ISRG has been the topic of several recent research reports. Truist Financial lowered their price target on shares of Intuitive Surgical from $605.00 to $590.00 and set a “buy” rating on the stock in a report on Wednesday, April 23rd. Citigroup raised their target price on Intuitive Surgical from $640.00 to $711.00 and gave the stock a “buy” rating in a report on Friday, January 24th. Erste Group Bank lowered Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research report on Monday, March 17th. JPMorgan Chase & Co. lifted their target price on shares of Intuitive Surgical from $575.00 to $675.00 and gave the company an “overweight” rating in a report on Friday, January 24th. Finally, UBS Group raised their price target on shares of Intuitive Surgical from $500.00 to $560.00 and gave the company a “neutral” rating in a research report on Monday, January 27th. Five investment analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $598.95.

Insider Transactions at Intuitive Surgical

In other news, CFO Jamie Samath sold 188 shares of the stock in a transaction that occurred on Friday, February 28th. The shares were sold at an average price of $566.94, for a total value of $106,584.72. Following the completion of the sale, the chief financial officer now owns 7,162 shares of the company’s stock, valued at $4,060,424.28. This represents a 2.56 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, EVP Brian Edward Miller sold 8,900 shares of Intuitive Surgical stock in a transaction that occurred on Tuesday, March 11th. The shares were sold at an average price of $485.07, for a total transaction of $4,317,123.00. Following the sale, the executive vice president now directly owns 5,758 shares in the company, valued at approximately $2,793,033.06. The trade was a 60.72 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 33,313 shares of company stock worth $17,229,143 in the last ninety days. Insiders own 0.70% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.